Robotic surgery enhances outcomes in rectal cancer procedures

Robotic-assisted rectal resection significantly reduces conversion rates and shortens hospital stays compared to open and conventional laparoscopic surgeries. In a study involving 106 non-metastatic rectal cancer patients, robotic surgery resulted in a conversion rate of 3.57% and an average hospital stay of 11.5 days, versus 17.91 days for open surgery. Moreover, specimen quality was substantially better in robotic (85.71%) and open surgeries compared to laparoscopic techniques (47.83%), supporting robotic surgery as a standard treatment option.